Castro W H, Meyer S J, Becke M E, Nentwig C G, Hein M F, Ercan B I, Thomann S, Wessels U, Du Chesne A E
Orthopaedisches Forschungsinstitut Münster, Germany.
Int J Legal Med. 2001;114(6):316-22. doi: 10.1007/s004140000193.
Volunteer studies of experimental, low-velocity rear-end collisions have shown a percentage of subjects to report short-lived symptoms, but the cause of these symptoms remains unknown. It is unclear whether the symptoms arise from biomechanical stress causing injury or from psychological stress causing symptom expectation and anxiety. Similarly, the cause of symptoms remains obscure in virtually all "whiplash" patients because it is impossible to identify acute pathology in many cases. In this study subjects were exposed to placebo collisions that almost completely lacked biomechanical stress. It was highly probable that if the symptoms reported following low-velocity collisions were not due to injury but to other factors (including misattribution of symptoms from other sources), then the proportion of subjects reporting symptoms would be similiar to that reported for volunteers in true (experimental) low-velocity, rear-end collisions. A total of 51 volunteers (33 males and 18 females, mean age 32.4 years) were recruited through local newspaper advertisements. An experimental set-up for a placebo collision was constructed using two standard European cars. At time T0, prior to the placebo collision, a history and physical examination was performed, including a psychological analysis (Freiburger Personality Inventory). A symptom history and physical examination were also performed at time T1, immediately after the placebo collision, and the subjects completed symptom questionnaires 3 days (time T2) and 4 weeks (time T3) after the placebo collision. Data analysis included a determination of the predictive value of psychological data for the presence of symptoms following exposure to a placebo collision. At time T1, 9 out 51 participants (17.6%) indicated symptoms. Within 3 days (time T2) after the placebo collision, 10 (19.6%) of the subjects had symptoms, and within 4 weeks (time T3) 5 subjects (9.8%) had symptoms. Of the last group, two of the five did not relate these symptoms to the "collision". Subjects who endorsed symptoms at time T1 had significantly higher scores on the psychological scale of psychosomatic disorders (measured at time T0). Subjects endorsing symptoms at time T2 had significantly higher scores on emotional instability. There was also a tendency to higher scores on this sub-scale for subjects with whiplash-associated disorders (WAD) at time T3. A discriminant analysis using all four psychological scales from time T0 had a power of 87%, 83% and 92% for correct classification of subjects as asymptomatic times T1, T2 and T3, respectively. Approximately 20% of subjects exposed to placebo, low-velocity rear-end collisions will thus indicate WAD, even though no biochemical potential for injury exists. Certain psychological profiles place an individual at higher risk for phenomenon.
对实验性低速追尾碰撞的志愿者研究表明,一定比例的受试者报告出现了短期症状,但这些症状的成因尚不清楚。目前尚不清楚这些症状是由导致损伤的生物力学压力引起的,还是由导致症状预期和焦虑的心理压力引起的。同样,几乎所有“挥鞭样损伤”患者的症状成因都不明朗,因为在很多情况下无法识别急性病变。在本研究中,受试者经历了几乎完全没有生物力学压力的安慰剂碰撞。如果低速碰撞后报告的症状不是由损伤引起的,而是由其他因素(包括将来自其他来源的症状错误归因)导致的,那么报告有症状的受试者比例很可能与在真实(实验性)低速追尾碰撞中志愿者报告的比例相似。通过当地报纸广告招募了51名志愿者(33名男性和18名女性,平均年龄32.4岁)。使用两辆标准欧洲汽车构建了一个安慰剂碰撞的实验装置。在时间T0,即安慰剂碰撞前,进行了病史和体格检查,包括心理分析(弗赖堡人格量表)。在时间T1,即安慰剂碰撞后立即进行了症状史和体格检查,受试者在安慰剂碰撞后3天(时间T2)和4周(时间T3)完成了症状问卷。数据分析包括确定心理数据对暴露于安慰剂碰撞后出现症状的预测价值。在时间T1,51名参与者中有9名(17.6%)表示有症状。在安慰剂碰撞后3天(时间T2)内,10名(19.6%)受试者出现症状,在4周(时间T3)内,5名(9.8%)受试者出现症状。在最后一组中,5名受试者中有2名不认为这些症状与“碰撞”有关。在时间T1报告有症状的受试者在身心障碍心理量表上的得分(在时间T0测量)显著更高。在时间T2报告有症状的受试者在情绪不稳定方面得分显著更高。在时间T3,患有挥鞭样损伤相关障碍(WAD)的受试者在该子量表上也有得分更高的趋势。使用时间T0的所有四个心理量表进行的判别分析,将受试者正确分类为在时间T1、T2和T3无症状的能力分别为87%、83%和92%。因此,即使不存在生化损伤可能性,约20%暴露于安慰剂低速追尾碰撞的受试者也会显示患有WAD。某些心理特征使个体出现这种现象的风险更高。